• Latest Posts
In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

Five recent advancements in ovarian cancer research over the past year

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

In Depth 3 May 2023

Immunotherapy in the fight against solid tumors

10 immunotherapy companies making waves in 2023

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

In Depth 11 Oct 2022

The biggest private biotech investments in September 2022

Podcast 8 Sep 2023

Beyond Biotech podcast 62 – cytokine-based drugs

CatalYm shows importance of GDF-15 in tumor immunotherapy resistance

Exeliom Biosciences closes €24M financing for lead candidate 

Ten Swedish companies spearheading the country’s biotech scene